Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.

Chow KH, Park HJ, George J, Yamamoto K, Gallup AD, Graber JH, Chen Y, Jiang W, Steindler DA, Neilson EG, Kim BYS, Yun K.

Cancer Res. 2017 Oct 1;77(19):5360-5373. doi: 10.1158/0008-5472.CAN-17-1294. Epub 2017 Aug 14.

2.

Teaching Medical Students About Conflicts of Interest.

Wayne DB, Green M, Neilson EG.

JAMA. 2017 May 2;317(17):1733-1734. doi: 10.1001/jama.2017.2079. No abstract available.

PMID:
28464151
3.

JASN's Silver Jubilee.

Nath KA, Neilson EG, Couser WG, Tisher CC, Grantham JJ.

J Am Soc Nephrol. 2015 Jul;26(7):1477-8. doi: 10.1681/ASN.2015050537. Epub 2015 Jun 4. No abstract available.

4.

Phosphatidylinositol 3-kinase signaling determines kidney size.

Chen JK, Nagai K, Chen J, Plieth D, Hino M, Xu J, Sha F, Ikizler TA, Quarles CC, Threadgill DW, Neilson EG, Harris RC.

J Clin Invest. 2015 Jun;125(6):2429-44. doi: 10.1172/JCI78945. Epub 2015 May 18.

5.

Dogs don't bark at parked cars.

Neilson EG.

J Am Soc Nephrol. 2013 May;24(6):863. doi: 10.1681/ASN.2013030324. No abstract available.

6.

Web Surveillance for CKD.

Neilson EG.

J Am Soc Nephrol. 2013 Jan;24(1):1-3. doi: 10.1681/ASN.2012111098. Epub 2012 Dec 6. No abstract available.

7.

Heart repair by reprogramming non-myocytes with cardiac transcription factors.

Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN.

Nature. 2012 May 13;485(7400):599-604. doi: 10.1038/nature11139.

8.

EGFR signaling promotes TGFβ-dependent renal fibrosis.

Chen J, Chen JK, Nagai K, Plieth D, Tan M, Lee TC, Threadgill DW, Neilson EG, Harris RC.

J Am Soc Nephrol. 2012 Feb;23(2):215-24. doi: 10.1681/ASN.2011070645. Epub 2011 Nov 17.

9.

Body fluid dynamics: back to the future.

Bhave G, Neilson EG.

J Am Soc Nephrol. 2011 Dec;22(12):2166-81. doi: 10.1681/ASN.2011080865. Epub 2011 Oct 27. Review.

10.

Transcriptional networks in epithelial-mesenchymal transition.

Venkov C, Plieth D, Ni T, Karmaker A, Bian A, George AL Jr, Neilson EG.

PLoS One. 2011;6(9):e25354. doi: 10.1371/journal.pone.0025354. Epub 2011 Sep 30.

11.

VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.

O'Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, Dewar R, Rocha RM, Brentani RR, Resnick MB, Neilson EG, Zeisberg M, Kalluri R.

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16002-7. doi: 10.1073/pnas.1109493108. Epub 2011 Sep 12.

12.

Effect of recommendations from reviewers suggested or excluded by authors.

Moore JL, Neilson EG, Siegel V; Associate Editors at Journal of American Society of Nephrology.

J Am Soc Nephrol. 2011 Sep;22(9):1598-602. doi: 10.1681/ASN.2011070643. Epub 2011 Aug 18. Erratum in: J Am Soc Nephrol. 2011 Oct;22(10):1953.

13.

Volume depletion versus dehydration: how understanding the difference can guide therapy.

Bhave G, Neilson EG.

Am J Kidney Dis. 2011 Aug;58(2):302-9. doi: 10.1053/j.ajkd.2011.02.395. Epub 2011 Jun 25.

14.

Hepatocyte-derived Snail1 propagates liver fibrosis progression.

Rowe RG, Lin Y, Shimizu-Hirota R, Hanada S, Neilson EG, Greenson JK, Weiss SJ.

Mol Cell Biol. 2011 Jun;31(12):2392-403. doi: 10.1128/MCB.01218-10. Epub 2011 Apr 11.

15.

Mechanisms of tubulointerstitial fibrosis.

Zeisberg M, Neilson EG.

J Am Soc Nephrol. 2010 Nov;21(11):1819-34. doi: 10.1681/ASN.2010080793. Epub 2010 Sep 23. Review.

16.

Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis.

Inoue T, Takenaka T, Hayashi M, Monkawa T, Yoshino J, Shimoda K, Neilson EG, Suzuki H, Okada H.

J Am Soc Nephrol. 2010 Dec;21(12):2047-52. doi: 10.1681/ASN.2010010003. Epub 2010 Sep 16.

17.
18.

Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.

Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG.

N Engl J Med. 2010 Jul 22;363(4):343-54. doi: 10.1056/NEJMoa0910500.

19.

The debate over health care reform: Houston, we have a problem.

Neilson EG.

J Clin Invest. 2009 Oct;119(10):2849-50. No abstract available.

20.

Dystroglycan in the diagnosis of FSGS.

Giannico G, Yang H, Neilson EG, Fogo AB.

Clin J Am Soc Nephrol. 2009 Nov;4(11):1747-53. doi: 10.2215/CJN.01510209. Epub 2009 Sep 24.

21.

Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.

Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, Neilson EG, Saito Y.

Am J Kidney Dis. 2009 Oct;54(4):653-64. doi: 10.1053/j.ajkd.2009.05.009. Epub 2009 Jul 17.

PMID:
19615802
22.

Case records of the Massachusetts General Hospital. Case 21-2009. A 61-year-old woman with abdominal pain, weight loss, and renal failure.

Neilson EG, Farris AB.

N Engl J Med. 2009 Jul 9;361(2):179-87. doi: 10.1056/NEJMcpc0810841. No abstract available.

PMID:
19587344
23.

Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis.

Tanjore H, Xu XC, Polosukhin VV, Degryse AL, Li B, Han W, Sherrill TP, Plieth D, Neilson EG, Blackwell TS, Lawson WE.

Am J Respir Crit Care Med. 2009 Oct 1;180(7):657-65. doi: 10.1164/rccm.200903-0322OC. Epub 2009 Jun 25.

24.

Biomarkers for epithelial-mesenchymal transitions.

Zeisberg M, Neilson EG.

J Clin Invest. 2009 Jun;119(6):1429-37. doi: 10.1172/JCI36183. Epub 2009 Jun 1. Review.

25.

Finding new sea legs for urine proteomics.

Neilson EG.

J Am Soc Nephrol. 2009 Jun;20(6):1162. doi: 10.1681/ASN.2009040372. Epub 2009 May 7. No abstract available.

26.

Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.

Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, Kubo A, Akai Y, Rankin EB, Neilson EG, Haase VH, Saito Y.

Am J Physiol Renal Physiol. 2008 Oct;295(4):F1023-9. doi: 10.1152/ajprenal.90209.2008. Epub 2008 Jul 30.

27.

Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.

Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA.

Cancer Res. 2008 Jun 15;68(12):4709-18. doi: 10.1158/0008-5472.CAN-07-6289.

28.

Baumol's curse on medicine.

Neilson EG.

J Am Soc Nephrol. 2008 Jun;19(6):1049-53. doi: 10.1681/ASN.2008040374. Epub 2008 May 7. No abstract available.

29.

A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1.

Starremans PG, Li X, Finnerty PE, Guo L, Takakura A, Neilson EG, Zhou J.

Kidney Int. 2008 Jun;73(12):1394-405. doi: 10.1038/ki.2008.111. Epub 2008 Apr 2.

30.

Increased hospital mortality in patients with bedside hippus.

Denny JC, Arndt FV, Dupont WD, Neilson EG.

Am J Med. 2008 Mar;121(3):239-45. doi: 10.1016/j.amjmed.2007.09.014.

PMID:
18328309
31.

Author misrepresentation in the submission of redundant papers.

Al-Awqati Q, Neilson EG.

Kidney Int. 2008 Mar;73(5):521. doi: 10.1038/sj.ki.5002791. No abstract available.

32.

Author misrepresentation in the submission of redundant papers.

Al-Awqati Q, Neilson EG.

J Am Soc Nephrol. 2008 Mar;19(3):422-3. doi: 10.1681/ASN.2007121321. Epub 2008 Feb 13. No abstract available.

33.

Participation of bone marrow cells in biliary fibrosis after bile duct ligation.

Asawa S, Saito T, Satoh A, Ohtake K, Tsuchiya T, Okada H, Neilson EG, Gotoh M.

J Gastroenterol Hepatol. 2007 Nov;22(11):2001-8.

PMID:
17914983
34.

The fructose nation.

Neilson EG.

J Am Soc Nephrol. 2007 Oct;18(10):2619-21. Epub 2007 Sep 5. No abstract available.

35.

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.

Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R.

Nat Med. 2007 Aug;13(8):952-61. Epub 2007 Jul 29.

PMID:
17660828
36.

Plasticity, nuclear diapause, and a requiem for the terminal differentiation of epithelia.

Neilson EG.

J Am Soc Nephrol. 2007 Jul;18(7):1995-8. Epub 2007 Jun 13. Review. No abstract available.

37.

A proximal activator of transcription in epithelial-mesenchymal transition.

Venkov CD, Link AJ, Jennings JL, Plieth D, Inoue T, Nagai K, Xu C, Dimitrova YN, Rauscher FJ, Neilson EG.

J Clin Invest. 2007 Feb;117(2):482-91.

38.

Chronic kidney disease progression.

Eddy AA, Neilson EG.

J Am Soc Nephrol. 2006 Nov;17(11):2964-6. Epub 2006 Oct 11. No abstract available.

39.

The downside of a drug-crazed world.

Neilson EG.

J Am Soc Nephrol. 2006 Oct;17(10):2650-1. Epub 2006 Sep 7. No abstract available.

40.

Mechanisms of disease: Fibroblasts--a new look at an old problem.

Neilson EG.

Nat Clin Pract Nephrol. 2006 Feb;2(2):101-8. Review.

PMID:
16932401
41.

Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.

Chen J, Chen JK, Neilson EG, Harris RC.

J Am Soc Nephrol. 2006 Jun;17(6):1615-23. Epub 2006 Apr 26.

42.

Toward a unified theory of renal progression.

Harris RC, Neilson EG.

Annu Rev Med. 2006;57:365-80. Review.

PMID:
16409155
43.

Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease.

Rossini M, Cheunsuchon B, Donnert E, Ma LJ, Thomas JW, Neilson EG, Fogo AB.

Kidney Int. 2005 Dec;68(6):2621-8.

44.

Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN.

Nishitani Y, Iwano M, Yamaguchi Y, Harada K, Nakatani K, Akai Y, Nishino T, Shiiki H, Kanauchi M, Saito Y, Neilson EG.

Kidney Int. 2005 Sep;68(3):1078-85.

45.
46.

Interventions to regulate ordering of serum magnesium levels: report of an unintended consequence of decision support.

Rosenbloom ST, Chiu KW, Byrne DW, Talbert DA, Neilson EG, Miller RA.

J Am Med Inform Assoc. 2005 Sep-Oct;12(5):546-53. Epub 2005 May 19.

47.

Antibodies against macrophages that overlap in specificity with fibroblasts.

Inoue T, Plieth D, Venkov CD, Xu C, Neilson EG.

Kidney Int. 2005 Jun;67(6):2488-93.

48.

Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.

Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL.

Oncogene. 2005 Jul 28;24(32):5053-68.

49.

Setting a trap for tissue fibrosis.

Neilson EG.

Nat Med. 2005 Apr;11(4):373-4. No abstract available.

PMID:
15812511
50.

Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.

Chen JK, Chen J, Neilson EG, Harris RC.

J Am Soc Nephrol. 2005 May;16(5):1384-91. Epub 2005 Mar 23.

Supplemental Content

Loading ...
Support Center